Skip to main content
Fig. 4 | Acta Neuropathologica Communications

Fig. 4

From: Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice

Fig. 4

Bexarotene treatment reverses sensorimotor deficits induced by cisplatin. Mice were treated with cisplatin followed by bexarotene and performance in the beam walking test was assessed as a measure of sensorimotor function. Time to cross the beam was recorded (n = 8 males and 4 females). Performance on narrow beam walking test measured by time required to cross the beam. Results are represented as mean ± SD. Two-way ANOVA followed by Tukey’s multiple comparisons test. ***p < 0.001

Back to article page